Pharma Market Access Custom Solutions
IHS Global Insight can advise pharmaceutical and biotech companies on pricing and reimbursement strategies, risk assessment, market access support, payor perspectives, and market scenario analyses. In addition to our considerable pricing and reimbursement experience, global strength, and adaptability, we have a detailed understanding of how to optimize market access strategies in a wide range of scenarios. We can also provide customized ad-hoc data on comparative international prices; reimbursement guidelines for pharmaceutical products; and quarterly presentations and bulletins on global pricing and reimbursement developments, including reimbursement decisions or risk-sharing agreements.
We can provide the following services:
- Answer any ad-hoc pricing queries: Ask questions about pricing strategies for specific drugs.
- Market Access Bulletins: Stay up to date with regular (daily/weekly/monthly) analyses of key developments in health technology assessments (HTAs), reimbursement decisions, and/or regulatory environments in a specified region or therapeutic area. Each update contains analysis on the significance and implications of each event.
- Quarterly Presentations: Receive insights on key developments within a particular theme of pricing and reimbursemet.
- Market Analyses: Get the latest scenario analyses of geographic or therapeutic segments delivered in reports, data sets, or online tools. Access comprehensive insights on comparative reimbursement strategies.
- Scenario Models Focusing on Emerging Markets (Brazil, Russia, India, China, Mexico, and Turkey-BRIC-MT): Obtain analyses on different scenarios of product launches and regulatory developments in markets that are developing their health technology assessments strategies, such as the BRIC-MT countries.
- Scenario Models Focusing on Japan and Asia: Scenario analyses of product launches and regulatory developments in markets that can be difficult to penetrate, such as Japan.
- Tailored Special Reports: Get customized reports (approximately 5-15 pages) exclusively produced for one client focusing on critical information to improve your business strategies and increase opportunities.
- Customized Multi-Client Studies: Syndicated market research reports that are initiated after consultation with multiple clients that provide the opportunity to validate and enrich the process. These studies focus on qualitative/quantitative surveys, market access scenarios, and market analysis.
|
|
|
